JPH02289569A - New production of pyrido(1,2-a)pyrimidine derivative - Google Patents

New production of pyrido(1,2-a)pyrimidine derivative

Info

Publication number
JPH02289569A
JPH02289569A JP2040817A JP4081790A JPH02289569A JP H02289569 A JPH02289569 A JP H02289569A JP 2040817 A JP2040817 A JP 2040817A JP 4081790 A JP4081790 A JP 4081790A JP H02289569 A JPH02289569 A JP H02289569A
Authority
JP
Japan
Prior art keywords
formula
compound
acid
pyrido
general formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2040817A
Other languages
Japanese (ja)
Other versions
JP2997494B2 (en
Inventor
Atsunori Sano
淳典 佐野
Masami Ishihara
正巳 石原
Jun Yoshihara
潤 吉原
Hiromi Nawa
名和 裕美
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tokyo Tanabe Co Ltd
Fujifilm Wako Pure Chemical Corp
Original Assignee
Wako Pure Chemical Industries Ltd
Tokyo Tanabe Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wako Pure Chemical Industries Ltd, Tokyo Tanabe Co Ltd filed Critical Wako Pure Chemical Industries Ltd
Priority to JP2040817A priority Critical patent/JP2997494B2/en
Publication of JPH02289569A publication Critical patent/JPH02289569A/en
Application granted granted Critical
Publication of JP2997494B2 publication Critical patent/JP2997494B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Abstract

PURPOSE:To obtain the title compound by making, from 3-cyano-4-imino- pyrido[1,2-a]pyrimidine derivative as starting material, a new intermediate either through another new intermediate or by direct tetrazole-cyclization of the nitrile group of said derivative and by hydrolysis of the resulting new intermediate. CONSTITUTION:A compound of formula I [R<1> and R<3> are each H or alkyl; R<2> and R<4> are each H, halogen, alkyl, phenyl or of formula II (R<5> is H or OH; R<6> is H or acyl; R<7> is H, alkyl or allyl)] is reacted with hydrazoic acid or its salt to effect tetrazole-cyclization of the nitrile group of said compound into a new compound of formula III followed by acting an acid or base on this compound to prepare a second new compound of formula IV, which is then hydrolyzed to obtain the objective compound, a pyrido[1,2-a]pyrimidine derivative of formula V. Alternatively, the compound of the formula I is, without through the new compound of the formula III, directly converted into the new compound of the formula IV, which is then hydrolyzed to obtain the objective compound of the formula V. The above process is excellent in terms of yield, safety, operability, etc.

Description

【発明の詳細な説明】 〔産業上の利用分野) 本発明は抗アレルギー剤として有用なピリド[1.2−
a]ピリミジン誘導体の新規な製造法に原子又は水酸基
を表わし、R6は水素原子又はアシル基を表わし、R7
は水素原子、低級アルキル基又はアリル基を表わす.)
を表わす.]で示さわるピリド[ 1. 2 − a 
]ビリミジン誘導体(以下、化合物(I]と略記する.
)及びそれらの塩類は、抗アレルギー作用を有する薬剤
として知られており、これらを有効成分とする各種抗ア
レルギー剤が一般に広く普及している。
Detailed Description of the Invention [Industrial Application Field] The present invention provides pyrido [1.2-
a] Novel method for producing pyrimidine derivatives represents an atom or a hydroxyl group, R6 represents a hydrogen atom or an acyl group, R7
represents a hydrogen atom, a lower alkyl group, or an allyl group. )
represents. ] pyrido [1. 2-a
] Virimidine derivative (hereinafter abbreviated as compound (I)).
) and their salts are known as drugs having anti-allergic effects, and various anti-allergic drugs containing these as active ingredients are generally widely used.

従来、この種化合物の製造法としては、例えば特開昭5
4−36294号公報、特開昭63−18351号公報
、特開昭63−246374号公報等に記載の如く、一
般式[V] 1{’ 《式中、81〜R4はH記と同じ.》 又は一般式[VI] R1 (式中、Rはメチル基又はエチル基を表わし、Rl,[
4は前記と同じ.)で示される化合物を種々のアジ化水
素酸塩と反応させて、テトラゾール環化する方法が最も
一般的であり、アジ化水素酸塩としてアジ化アルミニウ
ム又はアジ化アンモニウムが反応に供されている。即ち
、J. Am. Cheffi.Soc., 80. 
3908−3911 (1985)に記載されている如
く、一般にニトリル基からテトラゾール環を形成する方
法に於てはアジ化ナトリウムの単独使用は高温、長時間
反応が必要で、しかも収率が低いため、塩化アンモニウ
ムや塩化アルミニウム等を併用してアジ化ナトリウムを
アジ化アンモニウムやアジ化アルミニウム等に変換させ
てテトラゾール環化反応を行うのが効果的とされており
、上記した如き公報類に於でもその方法が採用さわてい
る。
Conventionally, as a method for producing this kind of compound, for example, JP-A-5
As described in JP-A No. 4-36294, JP-A-63-18351, JP-A-63-246374, etc., the general formula [V] 1{' ``In the formula, 81 to R4 are the same as in H. 》 or general formula [VI] R1 (wherein, R represents a methyl group or an ethyl group, Rl, [
4 is the same as above. The most common method is to react the compounds shown in ) with various hydrogen azide salts to form tetrazole cyclization, and aluminum azide or ammonium azide is used as the hydrogen azide salt. . That is, J. Am. Cheffi. Soc. , 80.
3908-3911 (1985), in general, in the method of forming a tetrazole ring from a nitrile group, using sodium azide alone requires a high temperature and long reaction time, and the yield is low. It is said to be effective to convert sodium azide into ammonium azide, aluminum azide, etc. using ammonium chloride, aluminum chloride, etc. in combination to carry out the tetrazole cyclization reaction, and the above-mentioned publications also describe this method. The method is being adopted.

しかしながら、このように塩化アンモニウムや塩化アル
ミニウム等を併用した場合でも、その収率はMax 5
0%強と決して高くはなく、しかもこれらの化合物を併
用することにより、いくつかの弊害が生じる。即ち、例
えば塩化アンモニウムを併用した場合、アジ化ナトリウ
ムはアジ化アンモニウムとして作用するわけであるが、
このアジ化アンモニウムは昇華性が非常に高く、高温下
、長時間、反応させると系外へ逃げてしまうために大過
剰使用する必要があり、効率が極めて悪い。
However, even when ammonium chloride, aluminum chloride, etc. are used in combination, the yield is only max.
The content is just over 0%, which is by no means high, and the combined use of these compounds causes some adverse effects. That is, for example, when used together with ammonium chloride, sodium azide acts as ammonium azide,
This ammonium azide has a very high sublimation property, and if reacted at high temperature for a long time, it escapes from the system, so it has to be used in large excess, which is extremely inefficient.

また、塩化アルミニウム等を併用した場合には、アジ化
ナトリウムは系内に於てはアジ化アルミニウム等アジ化
水素酸の多価金属塩として働くが、アジ化アルミニウム
等のアジ化水素酸の多価金属塩は爆発性を有する極めて
危険な化合物なので、取り扱いには厳重な往意と熟練を
要する。また,これら多価金属塩を反応に用いた場合に
は反応後はテトラゾール環化反応に関与しないアジド基
が多量に残存するため、大量のアジ化水素が発生するこ
とになり、大気汚染等の問題が生じる上にアルミニウム
等に起因する金属廃棄物処理も必要となってくる。
In addition, when aluminum chloride, etc. is used together, sodium azide acts as a polyvalent metal salt of hydrazoic acid such as aluminum azide in the system; Since valent metal salts are extremely dangerous compounds with explosive properties, strict care and skill are required when handling them. In addition, when these polyvalent metal salts are used in the reaction, a large amount of azide groups that do not participate in the tetrazole cyclization reaction remain after the reaction, resulting in the generation of a large amount of hydrogen azide, which causes air pollution, etc. In addition to the problems that arise, it becomes necessary to dispose of metal waste caused by aluminum and the like.

従って、これらの方法を実用化(金業化》しようとした
場合には、収率の低いことはもとより作業環境及び作業
者の安全性確保の問題、大気汚染防止のための設備の問
題、産業廃棄物処理に要する時間と労力等の問題等を考
慮しなければならず、その改善が切に望まれていた。
Therefore, when attempting to put these methods into practical use (commercialization), there are problems in addition to low yields, problems in ensuring the safety of the working environment and workers, problems with equipment for preventing air pollution, and problems with the industry. Problems such as the time and labor required for waste treatment had to be taken into consideration, and improvements in these issues were desperately desired.

(発明の目的) 本発明は上記した如き現状に鑑みなさわたもので、安全
性か高く、大気汚染や産業廃棄物等の問題も少なく、容
紡に且つ高収率で目的とする化合物[I]が得られる、
化合物[I]の新規で効果的な製造法を提供することを
目的とする。
(Objective of the Invention) The present invention was developed in view of the current situation as described above. I] is obtained,
The purpose of the present invention is to provide a new and effective method for producing compound [I].

(発明の構成) 木発明は、一般式[II1] [式中、81及びB3は夫々独立して水素原子又は低級
アルキル基を表わし、R2及びR4は夫々独立して水素
原子、ハロゲン原子、低級アルキル基、原子又は水酸基
を表わし、R6は水素原子又はアシル基を表わし、R7
は水素原子、低級アルキル基又はアリル基を表わす.》
を表わす.Jで示される化合物を、(itアジ化水素酸
と反応させるか、又は、(i)アジ化水素酸の塩類と反
応させて一般式[IV]また、本発明は一般式[I[1
] (式中、Rl〜R4は前記と同じ。)で示さわる化合物
とした後、これに酸又は塩基を作用させることにより、
一般式[11] H4 (式中、R1〜R4は而記と同じ。)で示される化合物
をアシ化水素酸と反応させることを特徴とする、一般式
[111 H4 (式中、R1〜R4は前記と同じ.)で示さわる化合物
とし、然る後これを加水分解することを特徴とする、一
般式[I] H′ (式中、R1〜R4は而記と同じ6)で示される化合物
の製造法の発明である。
(Structure of the Invention) The invention relates to the general formula [II1] [wherein 81 and B3 each independently represent a hydrogen atom or a lower alkyl group, and R2 and R4 each independently represent a hydrogen atom, a halogen atom, a lower represents an alkyl group, atom or hydroxyl group, R6 represents a hydrogen atom or an acyl group, R7
represents a hydrogen atom, a lower alkyl group, or an allyl group. 》
represents. The compound represented by J is reacted with (it hydrazidic acid or (i) a salt of hydrazidic acid to form the general formula [IV]).
] (In the formula, Rl to R4 are the same as above.) By reacting this with an acid or a base,
General formula [111] H4 (wherein, R1 to R4 are the same as below) is reacted with hydroacetic acid. is the same as above.), and then hydrolyzed, it is characterized by the general formula [I] H' (wherein R1 to R4 are the same as 6 as above). This is an invention of a method for producing a compound.

また、本発明は一般式[I[[] κ9 (式中、81〜R4は前記と同じ.)で示される化合物
の製造法の発明である。
Further, the present invention is a method for producing a compound represented by the general formula [I[[]κ9 (wherein 81 to R4 are the same as above).

H′ (式中、Rl,R4は前記と同じ,)で示される化合物
をアジ化水素酸の塩類と反応させることを特徴とする、
一般弐[rV] 《式中、Rl〜R4は航記と同じ.)で示される化合物
の製造法の発明である。
It is characterized by reacting a compound represented by H′ (wherein Rl and R4 are the same as above) with a salt of hydrazidic acid,
General 2 [rV] <<In the formula, Rl~R4 are the same as in the navigation. ) is an invention of a method for producing a compound represented by

史にまた、本発明は−・般式[rV] (式中、l{ +,R4は萌記と同じ。}で示される化
合物の製造法の発明である。
Additionally, the present invention is an invention of a method for producing a compound represented by the general formula [rV] (wherein, l{ +, R4 are the same as in Moeki).

史に、本発明は一般式[IV] (式中、R1〜R4は市1記と同じ。)で示される化合
物の発明である。
Historically, the present invention is an invention of a compound represented by the general formula [IV] (wherein R1 to R4 are the same as in Ichiki 1).

また、本発明は一般式[11] (式中、1{1〜R4は前記と同じ.}で示される化合
物に酸又は塩基を作用させることを特徴とする、一般式
[11 H4 《式中、R’−R’は而記と同じ,)で示される化合物
の発明である。
The present invention also provides a compound of the general formula [11] (wherein 1 {1 to R4 are the same as above), which is characterized by reacting an acid or a base with a compound represented by the general formula [11 H4 (in the formula) , R'-R' is the same as below.

即ち、本発明は、一般式[II1]で示される化合物(
以下、化合物[I[1]と略記する。)を出発原料とし
、これのニトリル基をテトラゾール環化させて一般式[
rV]で示される化合物(以下、化合物[IV]と略記
する.)を経由して、或は経由せずに一般式[11]で
示される化合物(以下、化合物[111と略記する.)
とした後、これを加水分解して化合物[I] とするも
ので、従来の方法と比べて収率の面からも、安全性の面
からも、作業性の面からも、極めて優れた製造方法を提
供するものである。
That is, the present invention provides a compound represented by the general formula [II1] (
Hereinafter, it will be abbreviated as compound [I[1]. ) is used as a starting material, and its nitrile group is cyclized with tetrazole to form the general formula [
rV] (hereinafter abbreviated as compound [IV]) or without via the compound represented by general formula [11] (hereinafter abbreviated as compound [111).
This is then hydrolyzed to form compound [I], which is an extremely superior production method compared to conventional methods in terms of yield, safety, and workability. The present invention provides a method.

本発明に係る一般式[I]〜[rV]で示される化合物
の11’及びl{Jは、夫々独立して水素原子、又は例
えばメチル基,エチル基,プロビル基.ブチル基,アミ
ル基等の低級アルキル基(直釦状、分枝状いずれにても
町)を表わし、R2及びR4は夫々独立して水素原子、
例えば塩素,臭素,弗素,沃素等のハロゲン原子、例え
ばメチル基,エチル基,プロビル基,ブチル基9アミル
基等の低級アルキル基(直釦状、分枝状いずれにても可
)、例えばメトキシ基.エトキシ基.プロボキシ基,ブ
トキシ基,アミロキシ基等の低級アルコキシ基《直釦状
、分枝状いずれにても可》、フエニル基、又は のR5は、水素原子、又は水酸基を表わし、R6は、水
素原子、又は例えばアセチル基,ブロとλニル基.ブチ
リル基等のアシル基を表わし、1{7は水素原子、例え
ばメチル基,エチル基.プロビル基,ブチル基、アミル
基等の低級アルキル基(直釦状、分枝状いずれにても可
)、又はアリル基を表わす。
In the compounds represented by formulas [I] to [rV] according to the present invention, 11' and l{J are each independently a hydrogen atom, or, for example, a methyl group, an ethyl group, a proyl group. It represents a lower alkyl group such as a butyl group or an amyl group (both straight and branched), and R2 and R4 are each independently a hydrogen atom,
For example, halogen atoms such as chlorine, bromine, fluorine, and iodine, lower alkyl groups (either straight or branched) such as methyl, ethyl, probyl, butyl, and 9-amyl groups, such as methoxy Base. Ethoxy group. R5 represents a hydrogen atom or a hydroxyl group, a lower alkoxy group such as a proboxyl group, a butoxy group, or an amyloxy group (either straight or branched), a phenyl group, and R6 represents a hydrogen atom, Or for example acetyl group, bro and λnyl group. It represents an acyl group such as a butyryl group, and 1{7 is a hydrogen atom, such as a methyl group or an ethyl group. It represents a lower alkyl group (either straight or branched) such as a probyl group, a butyl group, or an amyl group, or an allyl group.

本発明の製造法は、大略二つの工程、即ち化合物[I1
1]のニトリル基をテトラゾール環化させて化合物[1
11とする工程と、化合物[I1]を加水分解してイミ
ノ基をケトン基に変換する工程とから成る。
The production method of the present invention consists of approximately two steps, namely, compound [I1
The nitrile group of [1] is tetrazole cyclized to form compound [1].
11, and a step of hydrolyzing compound [I1] to convert an imino group into a ketone group.

以下、夫々の工程について詳細に説明する。Each step will be explained in detail below.

合  m から化Δ  ■ を ゛1する工化合物[1
111から化合物[I1]を製造する方法としては、(
it化合物[II1]をアジ化水素酸と反応させてニト
リル基をテトラゾール環化させ、直接、化合物[nlを
製造する方法と、(i)化合物[I11Jをアジ化水素
酸の塩類と反応させてニトリル基をテトラゾール環化さ
せ、化合物[rV]とした後、これに酸又は塩基を作用
させて、化合物[111を製造する方法とがある。
A chemical compound [1
As a method for producing compound [I1] from 111, (
A method for directly producing a compound [nl by reacting the it compound [II1] with hydrazoic acid to form a tetrazole cyclization of the nitrile group; There is a method of producing compound [111] by cyclizing a nitrile group with tetrazole to form compound [rV], and then reacting this with an acid or a base.

(i)の場合のテトラゾール環化反応に用いるアジ化水
素酸は、遊離の酸をそのまま又は水溶液等の溶液で用い
てもよいか、通常、爆発、中毒等の危険を避けるため、
反応器内で、アジ化水素酸の塩類に酸を作用させること
により遊離させる方法が採用される。
In the case of (i), the hydrazoic acid used in the tetrazole cyclization reaction may be used as a free acid or in a solution such as an aqueous solution.Usually, to avoid dangers such as explosion and poisoning,
A method is adopted in which the salts of hydrazidic acid are liberated by acting on them with an acid in a reactor.

1i)及び(j)の方法で用いられるアジ化水素酸の塩
類としては、例えばアジ化ナトリウム,アジ化カリウム
等のアルカリ金属塩類、アジ化カルシウム.アジ化マグ
ネシウム等のアルカリ十類金属塩類、アジ化アルミニウ
ム,アジ化亜鉛,アジ化錫等その他の多価金属塩類、ア
ジ化アンモニウム、例えばアジ化トリメチルアンモニウ
ム.アジ化アニリン等の有機塩基の塩類等各種のアジ化
水素酸塩が挙げられるが、市販されているアジ化水素酸
塩の中で最も取り扱い易く、しかも安価なアジ化ナトリ
ウムの単独使用が最も好ましい。即ち、本発明の製造法
に於てはアジ化ナトリウム単独でも緩和な反応条件でテ
トラゾール環化反応は充分進行し、短時間で、しかも極
めて高収率で目的とするテトラゾール体が得られるので
従来法のように態々塩化アンモニウムや塩化アルミニウ
ム等を併用する必要かなく、塩化アンモニウムや塩化ア
ルミニウム等を併用した場合の先に述べた如き間迦点は
全て回避し得る。
Examples of the salts of hydrazidic acid used in methods 1i) and (j) include alkali metal salts such as sodium azide and potassium azide, calcium azide. Alkali group 10 metal salts such as magnesium azide, other polyvalent metal salts such as aluminum azide, zinc azide, tin azide, ammonium azide, such as trimethylammonium azide. There are various hydroazide salts such as salts of organic bases such as aniline azide, but among the commercially available hydroazide salts, it is most preferable to use sodium azide alone as it is the easiest to handle and is also inexpensive. . That is, in the production method of the present invention, the tetrazole cyclization reaction proceeds sufficiently under mild reaction conditions even with sodium azide alone, and the desired tetrazole compound can be obtained in a short time and in an extremely high yield. It is not necessary to use ammonium chloride, aluminum chloride, etc. in combination as in the case of the method, and all the problems mentioned above when using ammonium chloride, aluminum chloride, etc. in combination can be avoided.

アジ化水素酸又はその塩類の使用量は、通常理.,it
量若しくは理論量より若干過剰量程度で充分高収率を達
成できるので、不要なアジ化水素酸の発生が極力抑えら
れ、特にアジ化ナトリウムを単独で用いた場合には不要
なアジ化水素酸の発生が殆どないので、大気汚染等の問
題も殆どなくなる。
The amount of hydrazoic acid or its salts to be used is within the normal range. ,it
Since a sufficiently high yield can be achieved with an amount slightly in excess of the amount or the theoretical amount, the generation of unnecessary hydrazoic acid is suppressed as much as possible, especially when sodium azide is used alone. Since there is almost no occurrence of air pollution, problems such as air pollution are almost eliminated.

本発明に係るテトラゾール環化反応の反応温度は、(i
l, (i)いずれの場合も、通常θ℃〜反応溶媒の岳
流温度のいずれの温度でもよく、反応時間をより短縮し
たい場合には温度は高い方が望ましいが、室温でも充分
反応は短時間で進行し、晶収率が達成される。反応時間
は反応温度により自ら異なるか、(it. (ii)い
ずれの場合も、通常数十分乃至数時間で充分である。
The reaction temperature of the tetrazole cyclization reaction according to the present invention is (i
l, (i) In either case, any temperature between θ°C and the temperature of the reaction solvent can be used.If you want to shorten the reaction time, a higher temperature is preferable, but the reaction is sufficiently short even at room temperature. Progressing over time, a crystal yield is achieved. The reaction time may vary depending on the reaction temperature (it. (ii) In either case, several tens of minutes to several hours is usually sufficient.

(itの場合のテトラゾール環化反応に用いられる反応
溶媒としては、ニトリル基のテトラゾール環化反応を阻
害せず、且つそれ自身、アジ化水素酸又はその塩類によ
り影響を受けることのない溶媒であわばいずれにてもよ
く、例えばメタノール,エタノール等のアルコール類、
アセトン,メチルエチルケトン等のケトン類、酢酸メチ
ル,酢酸エチル等のエステル類、ベンゼン.トルエン等
の芳香族炭化水素類、クロロホルム.ジクロルメタン等
のハロゲン化炭化水素類、アセトニトリル、テトラヒド
口フラン(丁肝)、N,N−ジメチノレホノレムアミド
(DMF)、ジメチルアセトアミド、ジオキサン、ジメ
チルスルホキシド、ヘキサメチル燐酸トリアミド(HM
PA)、エーテル、各種グライム,ジクライム類、水等
の溶媒のほか、酢酸.ギ酸等の酸性の有機溶媒が挙げら
れ、これらを単独で用いても適宜混合して用いても良い
が、上記要件を満足し得る溶媒であれば特にこれらに限
定されるものではない。
(The reaction solvent used in the tetrazole cyclization reaction in the case of it is a solvent that does not inhibit the tetrazole cyclization reaction of the nitrile group and is not itself affected by hydrazoic acid or its salts. For example, alcohols such as methanol and ethanol,
Ketones such as acetone and methyl ethyl ketone, esters such as methyl acetate and ethyl acetate, benzene. Aromatic hydrocarbons such as toluene, chloroform. Halogenated hydrocarbons such as dichloromethane, acetonitrile, tetrahydrofuran, N,N-dimethynorephonolemamide (DMF), dimethylacetamide, dioxane, dimethylsulfoxide, hexamethylphosphoric triamide (HM
In addition to solvents such as PA), ether, various glymes, diclimes, and water, acetic acid. Examples include acidic organic solvents such as formic acid, and these may be used alone or in an appropriate mixture, but are not particularly limited to these as long as they can satisfy the above requirements.

(itの場合に於いて、アジ化水素酸の塩類からアジ化
水素酸を遊離させるために使用する酸の袖類には、特に
制約はなく、例えば塩酸,硫酸.硝酸等の鉱酸類、ギ酸
,酢酸,ベンゼンスルホン酸.トシル酸.メタンスルホ
ン酸等の有機酸類が例示される、また、その使用量は、
アジ化水素酸の塩類からアジ化水素酸を遊離させるのに
十分な量であわばよいが、テトラゾール環化反応に悪影
響を及ぼす恐れがある酸を使用する場合は、アジ化水素
酸を遊離させるのに必要な最小限の量を使用すべきであ
るのに対して、酢酸,ギ酸等、テトラゾール環化反応に
悪影響を及ぼす恐れがなく、且つ、それ自体、溶媒とし
て機能する酸を使用する場合には、その使用量に制約は
なく、特に他の溶媒を併用する必要もない。反応終了後
は、要すれば反応液に水を加え、析出晶を枦取する等常
法に従って化合物[111を単離すれば良い。
(In the case of IT, there are no particular restrictions on the type of acid used to liberate hydrazoic acid from its salts, such as hydrochloric acid, sulfuric acid, mineral acids such as nitric acid, formic acid, etc.) , acetic acid, benzenesulfonic acid, tosic acid, and methanesulfonic acid.
It is sufficient to use an amount sufficient to liberate hydrazidic acid from the salts of hydrazidic acid, but when using an acid that may have a negative effect on the tetrazole cyclization reaction, it is sufficient to liberate hydrazidic acid. On the other hand, when using an acid such as acetic acid or formic acid, which has no adverse effect on the tetrazole cyclization reaction and which itself functions as a solvent. There are no restrictions on the amount used, and there is no need to use other solvents. After the reaction is completed, compound [111 may be isolated according to a conventional method such as adding water to the reaction solution and scraping off precipitated crystals, if necessary.

(ii)の場合に用いられる反応溶媒としては、(i)
の場合に例示される各柿溶媒のうち、酢酸.ギ酸等の酸
性の有機溶媒を除いた全ての溶媒が挙げられる。
The reaction solvent used in the case of (ii) is (i)
Among the persimmon solvents exemplified in the case of , acetic acid. All solvents except acidic organic solvents such as formic acid may be mentioned.

(ii)の場合、化合物[I[1]のテトラゾール環化
反応により、化合物[IV]が得られるが、化合物[r
V1はいずれも文献未載の新規化合物である。
In the case of (ii), compound [IV] is obtained by the tetrazole cyclization reaction of compound [I[1], but compound [r
All of V1 are new compounds that have not been described in any literature.

化合物[rV]は、テトラゾール環化反応終了後反応液
を中和し、析出した結晶を枦取するなどして惟離しても
よいが、これを単離せずに反応液に直接酸又は塩基を作
用させて、次の閉環工桿に進むこともd1能である。
Compound [rV] may be isolated by neutralizing the reaction solution after the completion of the tetrazole cyclization reaction and taking off the precipitated crystals, but it is also possible to separate the compound [rV] by directly adding an acid or base to the reaction solution without isolating the crystals. It is also d1 ability to act and proceed to the next ring closing mechanism.

(ii)に於て、化合物]■1に作用させる酸として、
例えば塩酸,硫酸.硝酸等の鉱酸や酢酸,ギ酸,ベンゼ
ンスルホン酸,トシル酸,メタンスルホン酸等の有機酸
等、各種プロトン酸や塩化アルミニウム,塩化亜鉛.四
塩化錫.六弗化アンチモン酸等のルイス酸等が挙げられ
、塩基としては、例えば水酸化ナトリウム,水酸化カリ
ウム等の苛性アルカリ、炭酸ナトリウム.炭酸カリウム
等の炭酸アルカリ、ナトリウムメトキシド,ナトリウム
エトキシド等の金属アルコキシド、アンモニア、例えば
ピリジン,トリエチルアミン等の有機塩基等が夫々挙げ
られる。
In (ii), as the acid acting on the compound]■1,
For example, hydrochloric acid, sulfuric acid. Mineral acids such as nitric acid, organic acids such as acetic acid, formic acid, benzenesulfonic acid, tosylic acid, methanesulfonic acid, various protonic acids, aluminum chloride, zinc chloride. Tin tetrachloride. Examples include Lewis acids such as hexafluorinated antimonic acid, and examples of bases include caustic alkalis such as sodium hydroxide and potassium hydroxide, sodium carbonate. Examples include alkali carbonates such as potassium carbonate, metal alkoxides such as sodium methoxide and sodium ethoxide, ammonia, and organic bases such as pyridine and triethylamine.

化合物[IV]に酸又は塩基を作用させて閉環させる工
程は、通常加温下、例えば60〜100℃で行われ、反
応時間は、通常1乃至数時間で充分である。反応溶媒と
しては、化合物[TV]を9離した場合には、通常、水
が用いられるが、勿論こわに限定されるものではなく、
テトラゾール環化反応に用いられる各種溶媒類も回様に
使用可能であることは言うまでもない。
The step of causing compound [IV] to undergo ring closure by acting with an acid or base is usually carried out under heating, for example at 60 to 100°C, and the reaction time is usually sufficient for one to several hours. As a reaction solvent, water is usually used when the compound [TV] is separated, but of course it is not limited to water.
It goes without saying that various solvents used in the tetrazole cyclization reaction can also be used.

反応終了後は、要すれば反応液に水を加えた後、例えば
塩酸.硫酸,硝酸等の鉱酸や酢酸,キ酸等の有機酸等を
用いて反応液を中和すわば化合物目I]が結晶として析
出するので、これを枦取する等常法に従いこれを単離す
れば良い。
After the reaction is completed, water is added to the reaction solution if necessary, and then water is added, for example, with hydrochloric acid. When the reaction solution is neutralized using a mineral acid such as sulfuric acid or nitric acid or an organic acid such as acetic acid or chloric acid, Compound I] will precipitate as crystals. Just let go.

尚、litの場合に於いて、酸の使用量がアジ化水素酸
を遊離させるのに十分ではないために、アジ化水素酸が
一部塩で存在する場合は、同一系内で(itの方法と(
j)の方法によるテトラゾール環化反応を同時に行うこ
とになるから、アジ化水素酸.の塩と化合物[II1]
 との反応により、生成した化合物[IV]を化合物[
111に変換するため、反応液全体に対して,(j)の
方法の、酸又は塩基による閉環工程を行う必要が生じる
In addition, in the case of lit, if the amount of acid used is not sufficient to liberate the hydrazoic acid, and some of the hydrazoic acid is present in the form of a salt, in the same system ( method and (
Since the tetrazole cyclization reaction by method j) is performed at the same time, hydrazoic acid. Salts and compounds [II1]
By reaction with, the generated compound [IV] is converted into compound [
In order to convert to 111, it is necessary to perform the ring-closing step using an acid or a base in method (j) on the entire reaction solution.

かくして(it又は(j)の方法により得られた化合物
[11]はいずれも文献未載の新規化合物である。
The compound [11] thus obtained by the method (it or (j)) is a new compound that has not been described in any literature.

Δ   II   か   八   r      ゛
M=化合物[I]は化合物[11]を水、又は含水有機
溶媒、例えば含水メタノール,含水エタノール.含水ア
セトン.含水アセトニトリル,含水THF,含水DMF
等中で常法に従い加水分解することにより容易に製せら
れる。反応は室温でも進行するが、反応時間を短縮する
ため、通常は加温下、例えば60〜110℃で行われる
。また、同しく反応時間を短縮するために、例えば塩酸
.硫酸,硝酸等の鉱酸や、ベンゼンスルホン酸,トシル
酸,メタンスルホン酸等の有機酸等を共存させること、
常法通りである。
Δ II or 8 r ゛M=Compound [I] is compound [11] mixed with water or a water-containing organic solvent such as water-containing methanol or water-containing ethanol. Hydrous acetone. Water-containing acetonitrile, water-containing THF, water-containing DMF
It can be easily produced by hydrolysis in a conventional manner. Although the reaction proceeds at room temperature, in order to shorten the reaction time, it is usually carried out under heating, for example at 60 to 110°C. In addition, in order to similarly shorten the reaction time, for example, hydrochloric acid. The coexistence of mineral acids such as sulfuric acid and nitric acid, and organic acids such as benzenesulfonic acid, tosylic acid and methanesulfonic acid,
As usual.

化合物[■]は単離したものを用いても良いが、化合物
[I[1]のデトラゾール環化反応により得られた反応
液(化合物[IV)を経由する方法の場合には、化合物
IN]を酸又は塩基で処理した反応液)をそのまま使用
しても一向に差し支えない。このことは出発原料[II
[]から中間体を単離することなく、1ポットで目的化
合物[I]が得られると言うことであり、本発明の有用
性をより高める実施態様となる。
Compound [■] may be used in isolation, but in the case of a method using a reaction solution (compound [IV)] obtained by the detrazole cyclization reaction of compound [I [1], compound IN] There is no problem in using the reaction solution (treated with acid or base) as it is. This means that the starting material [II
This means that the target compound [I] can be obtained in one pot without isolating the intermediate from [], and this is an embodiment that further enhances the usefulness of the present invention.

加水分解反応終了後は、冷却し、析出した結晶を枦取す
る等、常法に従って化合物[I]を単離すれば良い。
After the hydrolysis reaction is completed, compound [I] may be isolated according to a conventional method, such as cooling and collecting precipitated crystals.

尚、上述の本発明の製造法に於て、化合物[I1〜[I
V]に係る置換基R l, H 7の中に反応に際して
、保護を必要とする官能基がある場合には、保護基の導
入工程及び脱保護工程が適宜組み入れられるべきである
ことは言うまでもないウ本発明に於て、出発原料として
用いられる化合物[Dl1は、例えばJ. Org. 
Chem., 51. 2988 −2994 (19
86)等に記載の方法に従い、エトキシメチレンマロン
ニトリルと2−アミノビリジン誘導体とをエタノール等
の溶媒中、室温下反応させることにより容易に得られる
ので、そのようにして得らわたものを用いることで足り
る。
In addition, in the production method of the present invention described above, compounds [I1 to [I
It goes without saying that if there is a functional group that requires protection in the substituents R 1 and H 7 related to V], a protecting group introduction step and a deprotection step should be incorporated as appropriate. C. In the present invention, the compound [Dl1] used as a starting material is described, for example, in J. Org.
Chem. , 51. 2988 -2994 (19
It can be easily obtained by reacting ethoxymethylenemalonitrile and a 2-aminopyridine derivative in a solvent such as ethanol at room temperature according to the method described in 86), etc., so use the product obtained in this way. That's enough.

尚、この化合物[I[[]は溶液中で互変異性化し、ピ
リミジン環が閉環した [IIIalでボされる構造と
ピリミジン環が開環した[III bJで示される横造
の両形態をとり得ることが上記文献で報告されている。
In addition, this compound [I[[] is tautomerized in solution, and has both the structure shown in IIIal, in which the pyrimidine ring is closed, and the horizontal structure in which the pyrimidine ring is opened, shown in IIIbJ. It has been reported in the above-mentioned literature that this can be obtained.

[II1 al           [111 bl
従って、本発明の出発物質も上記[II1 al , 
[III blの両形態をとり得るが、本明細書に於て
は、便宜L化合物[II1]の枯造を[II[ alと
して説明を行っている。
[II1 al [111 bl
Therefore, the starting materials of the present invention also have the above-mentioned [II1 al,
Although it can take both forms of [IIIbl], in this specification, for convenience, the drying of L compound [II1] is explained as [II[al].

以ドに参考例及び実施例を挙げるが、本発明はこれら参
考例、実施例により何ら制約を受けるものではない。
Reference examples and examples are listed below, but the present invention is not limited in any way by these reference examples and examples.

〔実施例〕〔Example〕

参考例 1、 エタノール20(7にエトキシメチレンマロンニトリル
I1.8g (97ミリモル)及び2−アミノー3ーメ
チルビリジンIO.5g (97ミリモル)を加え、室
温F2時間撹拌反応させた。反応後析出した結晶を1戸
取し、3−シアノー4−イミノー9−メチル−48−ビ
リド[1.2−a]ピリミジン13.5gを得た。収率
 76%。
Reference Example 1: To ethanol 20 (7) were added 1.8 g (97 mmol) of ethoxymethylenemalonitrile I and 0.5 g (97 mmol) of 2-amino-3-methylpyridine, and the reaction was stirred at room temperature F for 2 hours. After the reaction, the precipitated crystals were One unit was taken and 13.5 g of 3-cyano-4-imino-9-methyl-48-pyrido[1.2-a]pyrimidine was obtained. Yield: 76%.

m,p, 164〜166℃。m, p, 164-166°C.

参考例 2. 参考例lに於で2−アミノー3−メチルピリジンを2−
アミノー4−メチルピリジンに置き換え、それ以外は参
考例1と全く同様にして3一シアノー4−イミノー8−
メチル−4H−ピリド[1.2−alビリミジンを得た
。収率 86%。
Reference example 2. In Reference Example 1, 2-amino-3-methylpyridine was converted into 2-
3-Cyano-4-imino-8-
Methyl-4H-pyrido[1,2-al pyrimidine was obtained. Yield: 86%.

m.p. 204〜206℃. 参考例 3. 参考例1に於て2−アミノー3−メチルピリジンを2−
アミノー5−メヂルビリジンに置き換え、それ以外は参
考例1と全く同様にして3−シアノー4−イミノー7−
メチル−4H−ピリド[1.2−alどリミジンを得た
。収率 8l%0m.p. 183 〜185℃。
m. p. 204-206℃. Reference example 3. In Reference Example 1, 2-amino-3-methylpyridine was converted into 2-
3-Cyano-4-imino-7-
Methyl-4H-pyrido[1,2-al]rimidine was obtained. Yield 8l%0m. p. 183-185℃.

参考例 4. 参考例lに於で2−アミノー3−メチルピリジンを2−
アミノー5−クロルビリジンに置き換・え、そわ以外は
参考例1と全く同桂にして3−シアノー4−イミノー7
−クロルー4H−ピリド11.2−a3ピリミジンを得
た。収率 72%。
Reference example 4. In Reference Example 1, 2-amino-3-methylpyridine was converted into 2-
3-cyano-4-imino-7 was obtained by using the same method as in Reference Example 1 except for replacing amino-5-chlorpyridine with 3-cyano-4-imino-7.
-Chloro-4H-pyrido 11.2-a3 pyrimidine was obtained. Yield 72%.

m.p. 227〜228℃. 参考例 5. 参考例1に於て2−アミノー3−メチルピリジンを2−
アミノビリジンに置き換え、そわ以外は参考例1と全く
同柱にして3−シアノー4−イミノー4H−ピリド[ 
1. 2 − a ]ピリミジンを得た。収率 79%
m. p. 227-228℃. Reference example 5. In Reference Example 1, 2-amino-3-methylpyridine was converted into 2-
3-cyano-4-imino-4H-pyrido[
1. 2-a]pyrimidine was obtained. Yield 79%
.

I.ρ.172〜175 ℃。I. ρ. 172-175℃.

参考例 6. 参考例lに於いて2−アミノー3−メチルピリジンを2
−アミノー3−フェノキシメチルビリジンに置き換え、
それ以外は参考例1と全く同社にして3−シアノー4−
イミノー9−フエノキシメチル−4H−ピット[ 1.
 2 − aコピリミジンを/j4だ。収率 72%。
Reference example 6. In Reference Example 1, 2-amino-3-methylpyridine was
- replaced with amino-3-phenoxymethylpyridine,
Other than that, it is completely same as Reference Example 1 and 3-Cyano 4-
imino-9-phenoxymethyl-4H-pit [1.
2-a Copyrimidine is /j4. Yield 72%.

m.p. 175℃。m. p. 175℃.

参考例 7. 参考例lに於いて2−アミノー3−メチルビリジンを2
−アミノー3−[(4−アセチルー3一ヒドロキシ−2
−n−プロビルフエノキシ)メヂル]ピリジンに置き換
え,それ以外は参考例1と全く同桂にして3−シアノー
4−イミノー9−[(4−アセチルー3−ヒドロキシ−
2−n−プロビルフェノキシ)メチル]−4H−ピリト
[l.2−alビリミジンを得た。収率 77%。
Reference example 7. In Reference Example 1, 2-amino-3-methylpyridine was
-Amino-3-[(4-acetyl-3-hydroxy-2
3-cyano-4-imino-9-[(4-acetyl-3-hydroxy-
2-n-propylphenoxy)methyl]-4H-pyrito[l. 2-al pyrimidine was obtained. Yield 77%.

m.p. 174℃。m. p. 174℃.

参考例 8. 参考例1に於いて2−アミノー3−メチルビリジンを2
−アミノー3−[(4−イソブロビルフェノキシ》メチ
ルJピリジンに置き換え、そわ以外は参考例lと全く同
様にして3−シアノー4−イミノー9−((4−イソブ
ロビルフェノキシ)メチルJ−4H−ピリト[1.2−
alピリミジンを得た。収率 42%。
Reference example 8. In Reference Example 1, 2-amino-3-methylpyridine was
-amino-3-[(4-isobrobylphenoxy)methyl J-3-cyano-4-imino-9-((4-isobrobylphenoxy)methyl J-4H- Pirit [1.2-
al pyrimidine was obtained. Yield 42%.

m.p. 130 〜1:12℃。m. p. 130~1:12℃.

実施例 l. HMPA  I00mlに3−シアノー4−イミノー9
−メチル−4H−ピリド[ 1. 2 − a ]ピリ
ミジン10.0g (54.3ミリモル)及びアジ化ナ
トリウム3.53g (54.3ミリモル)を加え、7
0℃で3時間撹拌反応させた。冷却後、反応液を希塩酸
で中和し、析出した結晶を枦取して3−(3−メチル−
2−ビリジル)アミノー2−(1B−テトラゾール−5
−イル)−2−プロペノニトリルの淡褐色粉末9.8g
を得た。収率 79%。
Examples l. 3-cyano 4-imino 9 in HMPA I00ml
-Methyl-4H-pyrido [1. 2-a] Add 10.0 g (54.3 mmol) of pyrimidine and 3.53 g (54.3 mmol) of sodium azide, and
The reaction was stirred at 0° C. for 3 hours. After cooling, the reaction solution was neutralized with diluted hydrochloric acid, and the precipitated crystals were collected to give 3-(3-methyl-
2-Biridyl)amino-2-(1B-tetrazole-5
-yl)-2-propenonitrile light brown powder 9.8g
I got it. Yield 79%.

m.9.  191℃(分解》。m. 9. 191℃ (decomposition).

IR(κB r) : 3050c+n−’ ,222
0CII+−’ ,1630cm−’’II−NMR 
 δppm  (DMSO−d6)  : 10.97
(d,  Ift,NH(;lI=  C>  、8.
79(d,  !11.  4−HJ、7.11(dd
,  Ill.5−111, 3.18(s, Ill
, NjjN−N−N)、2.41(s, 3HJ:I
I3)。
IR(κB r): 3050c+n-', 222
0CII+-', 1630cm-''II-NMR
δppm (DMSO-d6): 10.97
(d, Ift, NH(;lI=C>, 8.
79(d, !11. 4-HJ, 7.11(dd
, Ill. 5-111, 3.18(s, Ill
, NjjN-N-N), 2.41(s, 3HJ:I
I3).

MS  (m/e) : 227  (M”)。MS (m/e): 227 (M”).

実施例 2. DMFI00dに3−シアノー4−イミノー9−メチル
−4H−ピリド[ 1. 2 − a ]ピリミジン1
0.0g (54.3ミリモル)及びアジ化ナトリウム
:l.53g (54.3ミリモル)を加え、70℃で
3時間撹拌反応させた。冷却後、反応液を希塩酸で中和
し、析出した結晶を枦取して3−(3−メチル−2−ビ
リジル)アミノー2−(il+−テトラゾール−5−イ
ル)−2−ブロペノニトリルの淡褐色粉末9.1gを得
た。収率 73%。
Example 2. 3-cyano-4-imino-9-methyl-4H-pyrido [1. 2-a]pyrimidine 1
0.0 g (54.3 mmol) and sodium azide: l. 53 g (54.3 mmol) was added, and the mixture was stirred and reacted at 70° C. for 3 hours. After cooling, the reaction solution was neutralized with dilute hydrochloric acid, and the precipitated crystals were collected to give a light brown color of 3-(3-methyl-2-biridyl)amino-2-(il+-tetrazol-5-yl)-2-bropenonitrile. 9.1 g of powder was obtained. Yield 73%.

実施例 3. メタノールl00rnlに3−シアノー4−イミノー9
−メチル−4H−とリド[1. 2 − a ]ビリミ
ジンIO.Og (54.3ミリモル)及びアジ化ナト
リウム3.53g (54.3ミリモル》を加え、撹拌
下3時間還流反応させた。冷却後、反応液を希塩酸で中
和し、析出した結晶を枦取して3−(3−メチルー2−
ビリジル)アミノー2−(IH−テトラソールー5−イ
ル)−2−プロベノニトリルの淡褐色粉末9.5gを得
た。収率 77%0 実施例 4. 水100rnlに3−シアノー4−イミノー9−メチル
−4H−ビリド[1.2−a]ビリミジンIO.Og(
54.3ミリモル)及びアジ化ナトリウム:l.53g
(54.:lミリモル)を加え、70℃で6時間撹拌反
応させた。冷却後、反応液を希塩酸で中和し、析出した
結晶を枦取して3−《3−メチル−2−ピリジル》アミ
ノー2−(IH−テトラゾール−5一イル)−2−プロ
ベノニトリルの淡褐色粉末7.5gを得た。収率 60
%。
Example 3. 3-cyano 4-imino 9 in methanol l00rnl
-Methyl-4H- and Lido [1. 2-a] pyrimidine IO. Og (54.3 mmol) and 3.53 g (54.3 mmol) of sodium azide were added, and the reaction was refluxed for 3 hours with stirring. After cooling, the reaction solution was neutralized with dilute hydrochloric acid, and the precipitated crystals were collected. and 3-(3-methyl-2-
9.5 g of light brown powder of (pyridyl)amino-2-(IH-tetrasol-5-yl)-2-probenonitrile was obtained. Yield 77%0 Example 4. 3-cyano-4-imino-9-methyl-4H-pyrido[1.2-a]pyrimidine IO in 100 rnl of water. Og(
54.3 mmol) and sodium azide: l. 53g
(54.:1 mmol) was added, and the mixture was stirred and reacted at 70° C. for 6 hours. After cooling, the reaction solution was neutralized with dilute hydrochloric acid, and the precipitated crystals were collected to obtain 3-<3-methyl-2-pyridyl>amino-2-(IH-tetrazol-5-yl)-2-probenonitrile. 7.5 g of light brown powder was obtained. Yield 60
%.

実施例 5. 酢酸 60ml!に3−シアノー4−イミノー9−メチ
ル−4H−ピリド[1.2−alピリミジン10.0g
 (54.3ミリモル》及びアジ化ナトリウム:j.5
3g(5C3ミリモル》を加え、115℃で−1時間撹
拌反応させた。冷却後、反応液に水を加え、析出した結
晶を枦取して4−イミノー9−メチル−3−(IH−テ
トラゾール−5−イル)−4H−ピリド[1.2−al
ピリミジンのべ褐色粉末13.5gを得た。収率 86
%。
Example 5. Acetic acid 60ml! 3-cyano 4-imino 9-methyl-4H-pyrido [1.2-al pyrimidine 10.0 g
(54.3 mmol) and sodium azide: j.5
3 g (3 mmol of 5C) was added, and the reaction was stirred at 115°C for -1 hour. After cooling, water was added to the reaction solution, and the precipitated crystals were collected. -5-yl)-4H-pyrido[1.2-al
13.5 g of a dark brown powder of pyrimidine was obtained. Yield 86
%.

m.p. 233℃(分解)。m. p. 233℃ (decomposition).

夏 R ( κ B r)  :  3400cm−’
,  +695CD+−’’II−NMR  δPpm
 ((:F3GOOD) : 9.66(s, III
,2−11)、9.23(d, I}I, 6−}1 
) , 8.22( d. IH, 8−11)、7.
79 (L, II1, 7−111、2.81(s,
 311, Gji3),MS (m/e):  22
7 (M”)。
Summer R (κBr): 3400cm-'
, +695CD+-''II-NMR δPpm
((:F3GOOD) : 9.66(s, III
, 2-11), 9.23(d, I}I, 6-}1
), 8.22 (d. IH, 8-11), 7.
79 (L, II1, 7-111, 2.81 (s,
311, Gji3), MS (m/e): 22
7 (M”).

実施例 6, IN塩酸 20rnlに3−(3−メチル−2−ビリジ
ル)アミノー2−(IH−テトラゾール−5−イル)−
2−プロベノニトリル2.0g (10.9ミリモル)
を加え、 100℃で1時間撹拌反応させた。冷却後、
析出した結晶を枦取し、4−イミノー9−メチル−3−
(IH−テトラゾールー5−イル)−4H−ピリド[ 
1. 2 − a ]ピリミジンの淡褐色粉末1.7g
を得た。収十 85%。
Example 6, 3-(3-methyl-2-biridyl)amino-2-(IH-tetrazol-5-yl)- in 20 rnl of IN hydrochloric acid
2-probenonitrile 2.0g (10.9 mmol)
was added, and the mixture was stirred and reacted at 100°C for 1 hour. After cooling,
The precipitated crystals were collected and 4-imino-9-methyl-3-
(IH-tetrazol-5-yl)-4H-pyrido [
1. 2-a] Light brown powder of pyrimidine 1.7 g
I got it. Yield: 85%.

m.l).  236℃(分解)。m. l). 236℃ (decomposition).

実施例 7. IN水酸化カリウム 20艷に3−(3−メチルー2−
ピリジル)アミノー2−(IH−テトラゾール−5−イ
ル)−2−プロベノニトリル2.0g (10.9ミリ
モル)を加え、 100℃で3.5時間撹拌反応させた
。冷却後、反応液を塩酸で中和し、析出した結晶を枦取
して4−イミノー9−メチル−3−(IH−テトラゾー
ル−5−イル・)−411−ビリド[1.2−a1ピリ
ミジンの淡褐色粉末1.78gを得た。収率89%0 111.1).  239℃(分解冫。
Example 7. IN potassium hydroxide 3-(3-methyl-2-
2.0 g (10.9 mmol) of pyridyl)amino-2-(IH-tetrazol-5-yl)-2-probenonitrile was added, and the mixture was reacted with stirring at 100°C for 3.5 hours. After cooling, the reaction solution was neutralized with hydrochloric acid, and the precipitated crystals were collected to give 4-imino-9-methyl-3-(IH-tetrazol-5-yl)-411-pyrido[1.2-a1 pyrimidine] 1.78 g of light brown powder was obtained. Yield 89%0 111.1). 239℃ (decomposition.

実施例 8. IN塩酸 25−に4−イミノー9−メチル−3−(I
I+−テトラゾール−5−イル)−4H−ピリド[1.
2−a]ピリミジン0.95g (4.2ミリモル》を
加え、80℃で3.5時間撹拌反応させた。冷却後、析
出した結晶を枦取し、9−メチル−3−(IH−テトラ
ゾールー5−イル)−4■−ピリド[1.2−a]ビリ
ミシン−4−オンの淡褐色粉末0.85gを得た。収率
 89%。
Example 8. IN Hydrochloric acid 25- to 4-imino-9-methyl-3-(I
I+-tetrazol-5-yl)-4H-pyrido [1.
2-a] 0.95 g (4.2 mmol) of pyrimidine was added, and the reaction was stirred at 80°C for 3.5 hours. After cooling, the precipitated crystals were collected, and 9-methyl-3-(IH-tetrazole- 0.85 g of light brown powder of 5-yl)-4■-pyrido[1.2-a]virimicin-4-one was obtained. Yield: 89%.

m.p.  277℃(分解)。m. p. 277°C (decomposition).

実施例 9. 酢酸 60mI!に3−シアノー4−イミノー9ーメヂ
ルー4H−ピリド[ 1. 2 − a ]ピリミジン
10.0g(54.3ミリモル)及びアジ化ナトリウム
3.53g (54.3ミリモル)を加え、115℃で
1時間撹拌反応させた。次いで、これに濃塩酸15m7
!を加え、再び100℃で2時間撹拌反応させた。冷却
後、M『出した結晶を枦取し、9−メチル−3−(II
+−テトラゾール−5−イル)−4H−ピリド[1.2
一alピリミジン−4−オンの淡褐色粉末9.1gを得
た。収率 73%。
Example 9. Acetic acid 60mI! 3-cyano 4-imino 9-medyru 4H-pyrido [1. 2-a] 10.0 g (54.3 mmol) of pyrimidine and 3.53 g (54.3 mmol) of sodium azide were added, and the reaction was stirred at 115° C. for 1 hour. Next, 15 m7 of concentrated hydrochloric acid was added to this.
! was added, and the mixture was stirred and reacted again at 100°C for 2 hours. After cooling, M's crystals were taken out and 9-methyl-3-(II
+-tetrazol-5-yl)-4H-pyrido [1.2
9.1 g of light brown powder of 1-alpyrimidin-4-one was obtained. Yield 73%.

m.p.  281℃(分解)。m. p. 281℃ (decomposition).

実施例 10. 水 8(lnJ!に3−シアノー4−イミノー9−メチ
ル−4H−ピリド[1. 2 − a ]ピリミジン1
0.0g(54.3ミリモル)、アジ化ナトリウム3.
53g ( 54.3ミリモル)及び濃塩酸5.5i 
(54ミリモル)を加え、室温下3時間撹拌反応させた
後、濃塩酸5.5gを追加し、90℃で更に1時間撹拌
反応させた。
Example 10. Water 8 (lnJ! to 3-cyano 4-imino 9-methyl-4H-pyrido[1.2-a]pyrimidine 1
0.0 g (54.3 mmol), sodium azide3.
53 g (54.3 mmol) and 5.5 i of concentrated hydrochloric acid
(54 mmol) was added, and the mixture was stirred and reacted at room temperature for 3 hours, and then 5.5 g of concentrated hydrochloric acid was added, and the mixture was further stirred and reacted at 90° C. for 1 hour.

冷却後、析出した結晶を枦取し,9−メチル−3−(I
I1−テトラゾール−5−イル)−4H−ビリト[1.
2−a]ピリミジン−4−オンの淡褐色粉末9.1gを
得た。収率 73%。
After cooling, the precipitated crystals were collected and 9-methyl-3-(I
I1-tetrazol-5-yl)-4H-birite [1.
2-a] 9.1 g of light brown powder of pyrimidin-4-one was obtained. Yield 73%.

m.p.  288℃《分解》。m. p. 288℃《Decomposition》.

実jfi例 11. 実施例9に於て3−シアノー4−イミノー9一メチル−
4日−ピリド[1.2−a]ピリミジンを3−シアノー
4−イミノー8−メチル−4H−とリド[1.2−a]
ピリミジンに置き換え、そわ以外は実施例9と全く同様
にして8−メチル−3−(IN−テトラゾール−5−イ
ル》−4H−ピリド[1.2−alピリミジン−4−オ
ンを得た。収率81%。
Actual JFI example 11. In Example 9, 3-cyano-4-imino-9-methyl-
4-day-pyrido[1.2-a]pyrimidine with 3-cyano4-imino8-methyl-4H- and lido[1.2-a]
8-Methyl-3-(IN-tetrazol-5-yl)-4H-pyrido[1.2-alpyrimidin-4-one was obtained in exactly the same manner as in Example 9 except that pyrimidine was substituted with pyrimidine. The rate is 81%.

m.9.  299℃(分解)。m. 9. 299°C (decomposition).

実施例 12. 実施例9に於て3−シアノー4−イミノー9一メチル−
4H−ピリド[1.2−alピリミジンを3−シアノー
4−イミノー7−メチル−4■−ピリド[1.2−al
ピリミジンに置き換え、そわ以外は実Mi例9と全く同
様にして7−メチル−3−(It−1一テトラゾール−
5−イル)−4H−ビリド[1.2−a]ピリミジン−
4−オンを得た。収千 87%。
Example 12. In Example 9, 3-cyano-4-imino-9-methyl-
4H-pyrido[1.2-alpyrimidine is converted into 3-cyano4-imino7-methyl-4■-pyrido[1.2-al
7-methyl-3-(It-1-tetrazole-7-methyl-3-(It-1-tetrazole-
5-yl)-4H-pyrido[1.2-a]pyrimidine-
4-on was obtained. Revenue: 87%.

rn.p.  305℃(分解)。rn. p. 305℃ (decomposition).

実h’h例 13. 実施例9に於て3−シアノー4−イミノー9メチル−4
H−ビリド[1. 2 − aコピリミジンを3−シア
ノー4−イミノー7−クロルー4H−ビリド[1.2−
a]ビリミジンに置き換え、それ以外は実施例9と全く
同様にして7−クロルー3−(Il1−テトラゾール−
5−イル)−4H−ピリド[1.2−a]ピリミジン−
4−オンを得た。収率 84%0m.ρ.295℃(分
解)。
Actual h'h example 13. In Example 9, 3-cyano 4-imino 9 methyl-4
H-Virid [1. 2-a Copyrimidine to 3-cyano-4-imino-7-chloro-4H-pyrido[1.2-
a] 7-chloro-3-(Il1-tetrazole-
5-yl)-4H-pyrido[1.2-a]pyrimidine-
4-on was obtained. Yield 84%0m. ρ. 295°C (decomposition).

実施例 14. 実施例9に於て3−シアノー4−イミノー9−メチル−
4H−ピリド[1.2−a]ピリミジンを3−シアノー
4−イミノー4H−ピット[1.2−a1ビリミシンに
置き換え、それ以外は実施例9と全く同様にして3−(
Il+−テトラゾール−5−イル)−4H−ピリド[ 
1. 2 − a ]ピリミジンー4一オンを得た。収
率 86%。
Example 14. In Example 9, 3-cyano 4-imino 9-methyl-
3-(
Il+-tetrazol-5-yl)-4H-pyrido [
1. 2-a]pyrimidine-4-one was obtained. Yield: 86%.

m.p.  307℃(分解)。m. p. 307℃ (decomposition).

実施例 15. 実施例5に於いて3−シアノー4−イミノー9−メチル
−4日一ピット[1.2−alピリミジンを3−シアノ
ー4−イミノー9−フェノキシメチル−4H−ピリド[
 1. 2 − a ]ピリミジンに置き換え、それ以
外は実施例5と全く同様にして4ーイミノー9−フェノ
キシメチル−3− (IH−テ.トラゾール−5−イル
)−4H−ピリド[1.2−a]ピリミジンを得た。収
十 61%、m.ρ.270℃(分解》. IR(κB『、cm−’) : 34QQ,16!IQ
, 1600, 1320,’H − N M R  
(270MHz, DMSO−di)δppm  : 
9.54(1N, s. 2−11), 9.13(I
ll, d, 6−1t). 8.26(Ill,d,
8一旧, 7.86(III. L, 7一11),7
.34(211, t. 3゜.5゜−II).7.1
0(2H, d, 2゜.6゜一旧, 7.00(IH
, L,4’−11),5.62(211, s, C
!!2). MS (m/s) : 129, 実施例 16. 実施例5に於いて3−シアノー4−イミノー9−メチル
−4H−ピリド[1.2−a]ピリミジンを3−シアノ
ー4−イミノー9−[(4−アセチルー3−ヒドロキシ
ー2−n−プロビルフェノキシ)メチル]一4H−ビリ
ド[1.2−a]ピリミジンに置き換え、それ以外は実
施例5と全く同様にして4−イミノー9−[(4−アセ
チルー3−ヒドロキシ−2−n−プロビルフェノキシ)
メチル]−3−(IH−テトラゾール−5−イル)−4
H−とリド[1.2−a]ピリミシンを得た。
Example 15. In Example 5, 3-cyano-4-imino-9-methyl-4-day-1-pit[1.2-alpyrimidine was converted to 3-cyano-4-imino-9-phenoxymethyl-4H-pyrido[
1. 2-a]pyrimidine, and otherwise the same procedure as in Example 5 was carried out to prepare 4-imino-9-phenoxymethyl-3-(IH-te.trazol-5-yl)-4H-pyrido[1.2-a] Pyrimidine was obtained. Collection: 61%, m. ρ. 270℃ (decomposition). IR (κB', cm-'): 34QQ, 16!IQ
, 1600, 1320,'H-NMR
(270MHz, DMSO-di) δppm:
9.54 (1N, s. 2-11), 9.13 (I
ll, d, 6-1t). 8.26 (Ill, d,
8-old, 7.86 (III. L, 7-11), 7
.. 34 (211, t. 3°.5°-II). 7.1
0(2H, d, 2゜.6゜old, 7.00(IH
, L, 4'-11), 5.62 (211, s, C
! ! 2). MS (m/s): 129, Example 16. In Example 5, 3-cyano-4-imino-9-methyl-4H-pyrido[1.2-a]pyrimidine was converted into 3-cyano-4-imino-9-[(4-acetyl-3-hydroxy-2-n-propylene). 4-imino-9-[(4-acetyl-3-hydroxy-2-n-propylene) was prepared in exactly the same manner as in Example 5, except that 4-imino-9-[(4-acetyl-3-hydroxy-2-n-propyridine) phenoxy)
methyl]-3-(IH-tetrazol-5-yl)-4
H- and lido[1.2-a]pyrimicin were obtained.

収″P.98%。Yield P.98%.

m.9. 286℃(分解)。m. 9. 286℃ (decomposition).

IR(KBr、cm−’) : 3150,1700,
 1630. ltioO,+270.. ’H − N M R  (270MHz, C?3G
OOD)δppm : 9.91(II, s, 2−
11). 9.1:l(Ill, d, 6−tl),
 8.76(lit,d,8−H), 8.08(II
I, t, 7−11), 7.92(III.d.5
゜−I+1 ,6.89(IH. d, 6゜−H),
 5.89(211. S,OCI+2). 2.90
(211. t,(;!!21;l12G+13)、2
.28(311.s.Cij3GO) . 1.69−
1.77(211,?, (:lhGjj2CII3)
,  1.08(:III,  t, c++.t),
MS  (mis) : 419, 実施例 17. 実施例5に於いて3−シアノー4−イミノー9−メチル
−4H−ビリド[1.2−a]ピリミジンを3−シアノ
ー4−イミノー9−[(4−イソブロビルフェノキシ》
メチル] −48−ピリド[1.2−a]ピリミシンに
置き換え、そわ以外は実施例5と全く同様にして4−イ
ミノー9−[(4一イソブロビルフェノキシ》メチル−
]−3−(IH一テトラゾール−5−イル)−4H−ピ
リド[1.2−alピリミジンを得た。収率 62%。
IR (KBr, cm-'): 3150, 1700,
1630. ltioO, +270. .. 'H-NMR (270MHz, C?3G
OOD) δppm: 9.91 (II, s, 2-
11). 9.1:l (Ill, d, 6-tl),
8.76 (lit, d, 8-H), 8.08 (II
I, t, 7-11), 7.92 (III.d.5
゜-I+1, 6.89 (IH. d, 6゜-H),
5.89 (211.S, OCI+2). 2.90
(211.t, (;!!21;l12G+13), 2
.. 28 (311.s.Cij3GO) . 1.69-
1.77 (211,?, (:lhGjj2CII3)
, 1.08(:III, t, c++.t),
MS (mis): 419, Example 17. In Example 5, 3-cyano-4-imino-9-methyl-4H-pyrido[1.2-a]pyrimidine was converted to 3-cyano-4-imino-9-[(4-isobrobylphenoxy]).
Methyl]-4-imino9-[(4-isobrobylphenoxy]methyl-
]-3-(IH-tetrazol-5-yl)-4H-pyrido[1.2-alpyrimidine was obtained. Yield 62%.

m.p. 277℃(分解)ウ I R ( K Br, cm”) : 3150,1
695, 1640, 1600,+250, ’It − N M R  (27QlllHx, C
F3C(IOC)δppm : 9.8B(団, s,
 2−tl). 9.07(III, d, 6一旧,
 8.72(IH,d,8−111. 8.02(Il
l, L, 7−}1), 7.29(2H,d, 3
゜,5゜−1!),7.fl7(28, d, 2゜,
6’−H). 5.81(211. s,(Jl■),
2.旧一2.96(IH, m, (Jj)、1.28
(68, s, (Jj3x 2)。
m. p. 277℃ (decomposition) IR (KBr, cm”): 3150,1
695, 1640, 1600, +250, 'It - N M R (27QllllHx, C
F3C (IOC) δppm: 9.8B (group, s,
2-tl). 9.07 (III, d, 6 old,
8.72 (IH, d, 8-111. 8.02 (Il
l, L, 7-}1), 7.29(2H, d, 3
゜, 5゜-1! ), 7. fl7(28, d, 2゜,
6'-H). 5.81 (211.s, (Jl■),
2. Old one 2.96 (IH, m, (Jj), 1.28
(68, s, (Jj3x 2).

MS  (m/s) : 361, 実施例 +8. 実施例9に於いて3−シアノー4−イミノー9−メチル
−4H−ピリド[1.2−a]ピリミジンを3−シアノ
ー4−イミノー9−フェノキシメチル−4H−ピリド[
1.2−a]ピリミジンに置き換え、それ以外は実施例
9と全く同桂にして9−フェノキシメチル−3−(IH
−テトラゾール−5−イル)−4H−ピリド[1.2−
a]ビリミジンー4−オンを得た。収十 75%。
MS (m/s): 361, Example +8. In Example 9, 3-cyano4-imino9-methyl-4H-pyrido[1.2-a]pyrimidine was converted to 3-cyano4-imino9-phenoxymethyl-4H-pyrido[1.2-a]pyrimidine.
9-phenoxymethyl-3-(IH
-tetrazol-5-yl)-4H-pyrido[1.2-
a] pyrimidin-4-one was obtained. Yield: 75%.

m.p. 281t: (分解)。m. p. 281t: (decomposition).

実施例 +9. 実施例9に於いて3−シアノー4−イミノー9ーメチル
−4H−ピリド[1.2−alピリミジンを3−シアノ
ー4−イミノー9−[(4−アセチルー3−ヒドロキシ
ー2−n−プロビルフェノキシ)メチル]−4H−ピリ
ド[1.2−a]ビリミシンに置き換え、それ以外は実
施例9と全く同様にして9−((4−アセチルー3−ヒ
ドロキシー2−n−プロビルフエノキシ)メチル]一3
−(IH−テトラゾール−5−イル》−4H−ピリド[
1.2−a]ピリミジン−4−オンを得た。
Example +9. In Example 9, 3-cyano-4-imino-9-methyl-4H-pyrido[1.2-alpyrimidine was converted to 3-cyano-4-imino-9-[(4-acetyl-3-hydroxy-2-n-propylphenoxy)]. 9-((4-acetyl-3-hydroxy-2-n-propylphenoxy)methyl)]-4H-pyrido[1.2-a]virimicin was replaced with 9-((4-acetyl-3-hydroxy-2-n-probylphenoxy)methyl) in the same manner as in Example 9 except for 13
-(IH-tetrazol-5-yl)-4H-pyrido[
1.2-a]pyrimidin-4-one was obtained.

収率 98%。Yield: 98%.

m.ρ.254℃《分解》。m. ρ. 254℃《Decomposition》.

実施例 20. 実施例9に於いて3−シアノー4−イミノー9−メチル
−4H−とリド[1,2−alピリミジンを3−シアノ
ー4−イミノー9−[(4−イソブロビルフェノキシ)
メチル]−4H−ピリド[1.2−alピリミシンに置
き換え、それ以外は実施例9と全く同任にして9−[(
4−イソプロビルフェノキシ)メチル]−3−(IH−
テトラゾール−5−イル》−4H−ピリド[1.2−a
lビリミジン−4−オンを得た。収率 82%。
Example 20. In Example 9, 3-cyano-4-imino-9-methyl-4H- and lido[1,2-alpyrimidine were converted into 3-cyano-4-imino-9-[(4-isobrobylphenoxy)].
9-[(
4-isopropylphenoxy)methyl]-3-(IH-
Tetrazol-5-yl]-4H-pyrido[1.2-a
1-pyrimidin-4-one was obtained. Yield: 82%.

m.p. 277℃(分解)。m. p. 277°C (decomposition).

(発明の効果) 本発明は、抗アレルギー剤として有用な一般式[I1で
示されるビリド[1.2−alピリミジン誘導体の新規
で[[つ極めて効果的な製造法を提供するものであり、
本発明の製造法によわば、緩和な反応条件で、容易に[
11》極めて高収率で目的とするピリド[1. 2 −
 a ]ピリミジン誘導体が得られる点に顕著な効果を
奏するものであるか、特.に、化合物[[IIJのニト
リル基のテトラゾール環化反応をアジ化ナトリウムを用
いて行った場合には、安全性が高く、しかも大気汚染や
産業廃棄物等の問題も少ないので史に効果は顕著となる
(Effects of the Invention) The present invention provides a novel and highly effective method for producing a birido[1,2-al pyrimidine derivative represented by the general formula I1, which is useful as an antiallergic agent.
According to the production method of the present invention, it is possible to easily [
11》Target pyrido in extremely high yield [1. 2-
a] Is it particularly effective in obtaining a pyrimidine derivative? In addition, when the tetrazole cyclization reaction of the nitrile group of the compound [[IIJ is carried out using sodium azide, it is highly safe and there are fewer problems such as air pollution and industrial waste, so it has a remarkable effect in history. becomes.

また、本発明の製造法によわば、出発物質である化合物
[11I]から1ポットで目的とするビリド[ 1. 
2 − a ]ピリミジン誘導体を得ることも出来、出
発物質それ自体も従来法のそれより6i!!かに合成が
容易である点等も本発明の大きな利点と言うことができ
る。
Further, according to the production method of the present invention, the desired viride [1.
2-a]pyrimidine derivatives can also be obtained, and the starting material itself is 6i! ! Another major advantage of the present invention is that it is easy to synthesize crab.

特許出願人 和光純薬工業株式会社 特許出願人 東京田辺製薬株式会社Patent applicant: Wako Pure Chemical Industries, Ltd. Patent applicant: Tokyo Tanabe Pharmaceutical Co., Ltd.

Claims (6)

【特許請求の範囲】[Claims] (1)一般式[III] ▲数式、化学式、表等があります▼[III] [式中、R^1及びR^3は夫々独立して水素原子又は
低級アルキル基を表わし、R^2及びR^4は夫々独立
して水素原子、ハロゲン原子、低級アルキル基、フェニ
ル基又は▲数式、化学式、表等があります▼(但し、R
^5は水素原子又は水酸基を表わし、R^6は水素原子
又はアシル基を表わし、R^7は水素原子、低級アルキ
ル基又はアリル基を表わす。)を表わす。]で示される
化合物を、(i)アジ化水素酸と反応させるか、又は(
ii)アジ化水素酸の塩類と反応させて一般式[IV]▲
数式、化学式、表等があります▼[IV] (式中、R^1〜R^4は前記と同じ。)で示される化
合物とした後、これに酸又は塩基を作用させることによ
り、一般式[II] ▲数式、化学式、表等があります▼[II] (式中、R^1〜R^4は前記と同じ。)で示される化
合物とし、然る後これを加水分解することを特徴とする
、一般式[ I ] ▲数式、化学式、表等があります▼[ I ] (式中、R^1〜R^4は前記と同じ。)で示される化
合物の製造法。
(1) General formula [III] ▲There are mathematical formulas, chemical formulas, tables, etc.▼ [III] [In the formula, R^1 and R^3 each independently represent a hydrogen atom or a lower alkyl group, and R^2 and Each R^4 is independently a hydrogen atom, halogen atom, lower alkyl group, phenyl group, or ▲a numerical formula, chemical formula, table, etc.▼(However, R
^5 represents a hydrogen atom or a hydroxyl group, R^6 represents a hydrogen atom or an acyl group, and R^7 represents a hydrogen atom, a lower alkyl group, or an allyl group. ). ] is reacted with (i) hydrazoic acid, or (
ii) React with salts of hydrazidic acid to form the general formula [IV]▲
There are mathematical formulas, chemical formulas, tables, etc. ▼ [IV] (In the formula, R^1 to R^4 are the same as above.) After forming the compound, by treating it with an acid or a base, the general formula [II] ▲There are mathematical formulas, chemical formulas, tables, etc.▼ [II] A compound represented by (in the formula, R^1 to R^4 are the same as above), which is then hydrolyzed. A method for producing a compound represented by the general formula [I] ▲Mathematical formulas, chemical formulas, tables, etc.▼[I] (In the formula, R^1 to R^4 are the same as above.)
(2)一般式[III] ▲数式、化学式、表等があります▼[III] (式中、R^1〜R^4は前記と同じ。)で示される化
合物をアジ化水素酸と反応させることを特徴とする、一
般式[II] ▲数式、化学式、表等があります▼[II] (式中、R^1〜R^4は前記と同じ。)で示される化
合物の製造法。
(2) General formula [III] ▲There are mathematical formulas, chemical formulas, tables, etc.▼ [III] (In the formula, R^1 to R^4 are the same as above.) Reacting the compound represented by hydrazoic acid A method for producing a compound represented by the general formula [II] ▲There are mathematical formulas, chemical formulas, tables, etc.▼ [II] (In the formula, R^1 to R^4 are the same as above.)
(3)一般式[III] ▲数式、化学式、表等があります▼[III] (式中、R^1〜R^4は前記と同じ。)で示される化
合物をアジ化水素酸の塩類と反応させることを特徴とす
る、一般式[IV] ▲数式、化学式、表等があります▼[IV] (式中、R^1〜R^4は前記と同じ。)で示される化
合物の製造法。
(3) General formula [III] ▲There are mathematical formulas, chemical formulas, tables, etc.▼ [III] (In the formula, R^1 to R^4 are the same as above.) A method for producing a compound represented by the general formula [IV] ▲Mathematical formula, chemical formula, table, etc.▼[IV] (In the formula, R^1 to R^4 are the same as above.) characterized by reaction. .
(4)一般式[IV] ▲数式、化学式、表等があります▼[IV] (式中、R^1〜R^4は前記と同じ。)で示される化
合物に酸又は塩基を作用させることを特徴とする、一般
式[II] ▲数式、化学式、表等があります▼[II] (式中、R^1〜R^4は前記と同じ。)で示される化
合物の製造法。
(4) General formula [IV] ▲There are mathematical formulas, chemical formulas, tables, etc.▼ [IV] (In the formula, R^1 to R^4 are the same as above.) The action of an acid or base on the compound represented by A method for producing a compound represented by the general formula [II] ▲There are mathematical formulas, chemical formulas, tables, etc.▼ [II] (In the formula, R^1 to R^4 are the same as above.)
(5)一般式[IV] ▲数式、化学式、表等があります▼[IV] (式中、R^1〜R^4は前記と同じ。)で示される化
合物。
(5) General formula [IV] ▲There are mathematical formulas, chemical formulas, tables, etc.▼ [IV] (In the formula, R^1 to R^4 are the same as above.) A compound represented by the following.
(6)一般式[II] ▲数式、化学式、表等があります▼[II] (式中、R^1〜R^4は前記と同じ。)で示される化
合物。
(6) General formula [II] ▲There are mathematical formulas, chemical formulas, tables, etc.▼ [II] (In the formula, R^1 to R^4 are the same as above.) A compound represented by the following.
JP2040817A 1989-02-27 1990-02-21 Novel production method of pyrido [1,2-a] pyrimidine derivatives Expired - Lifetime JP2997494B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2040817A JP2997494B2 (en) 1989-02-27 1990-02-21 Novel production method of pyrido [1,2-a] pyrimidine derivatives

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP4629589 1989-02-27
JP1-46295 1989-02-27
JP2040817A JP2997494B2 (en) 1989-02-27 1990-02-21 Novel production method of pyrido [1,2-a] pyrimidine derivatives

Publications (2)

Publication Number Publication Date
JPH02289569A true JPH02289569A (en) 1990-11-29
JP2997494B2 JP2997494B2 (en) 2000-01-11

Family

ID=26380331

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2040817A Expired - Lifetime JP2997494B2 (en) 1989-02-27 1990-02-21 Novel production method of pyrido [1,2-a] pyrimidine derivatives

Country Status (1)

Country Link
JP (1) JP2997494B2 (en)

Also Published As

Publication number Publication date
JP2997494B2 (en) 2000-01-11

Similar Documents

Publication Publication Date Title
NO860199L (en) INTERMEDIATES FOR THE PREPARATION OF 6,7-DISUBSTITUTED 1-CYCLOPROPYL-1,4-DIHYDRO-4-OXO-1,8-NAFTYRIDINE-3-CARBOXYL ACID.
JPS6016438B2 (en) Imidazoquinoline derivatives
CA1082193A (en) Substituted tetrazole compounds
EP0053789B1 (en) 2-pyridinecarboxamide derivative, process for preparing same and pharmaceutical composition, useful as an anti-allergic agent
DD142343A5 (en) PROCESS FOR PREPARING 1-OXO-1H-PYRIMIDO SQUARE BRACKET ON 6.1-B SQUARE BRACKET TO BENZTHIAZOLENE
Kappe et al. Quinolizines and indolizines. Part 16. Synthesis of pyrrolo [3, 2, 1‐ij] quinolin‐4‐ones with potential fungicidal activity
JPH02289569A (en) New production of pyrido(1,2-a)pyrimidine derivative
JPS63179856A (en) Production of quinolonecarboxylic acid derivative and intermediate thereof
JPS63141969A (en) Novel imidazole derivative
JPS6191184A (en) 2-anilino-5-(1h-tetrazol-5-yl)pyrimidine-4(3h)-one derivative
US2839529A (en) Isothiazole compounds
CN109153652B (en) Process for preparing 1- (arylmethyl) quinazoline-2, 4(1H,3H) -diketone
NO130329B (en)
JPH02229196A (en) Cephalosporin derivative and preparation thereof
US5081243A (en) Process for producing 3-tetrazolyl pyrido[1,2-a]pyrimidine derivatives
IE831945L (en) Bis-esters of 4,5-di (hydroxymethyl)-2-oxo-1, 3 dioxoles.
JPS6011913B2 (en) 1,8-naphthyridine derivative and its manufacturing method
JPS5916878A (en) Production of 2,4-dihydroxy-3-acetylquinoline
JPH07121931B2 (en) Benzo [b] furan derivative
CA1089854A (en) Pyrazolo[1,5-a]pyrido[4,3-d]pyrimidin-9(4h)- one and derivatives thereof
Monge et al. Synthesis of 6‐amino‐2‐aryl‐1, 2‐dihydro‐3H‐pyrido [2, 3‐d] pyrimidin‐4‐one derivatives
JPS6110587A (en) 1-azaxanthone-3-carboxylic acid derivative and preparation thereof
US3855232A (en) Preparation of 1-(lower-alkyl)-1,4-dihydro-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylate
JP2837449B2 (en) Method for producing pyrido [1,2-a] pyrimidine derivative
JPS58167590A (en) Substituted 1h-pyrazolo(1,5-a)pyrimidine and manufacture

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313115

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20081029

Year of fee payment: 9

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20101029

Year of fee payment: 11

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20101029

Year of fee payment: 11

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20101029

Year of fee payment: 11

R371 Transfer withdrawn

Free format text: JAPANESE INTERMEDIATE CODE: R371

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20101029

Year of fee payment: 11

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

EXPY Cancellation because of completion of term
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20101029

Year of fee payment: 11